Author:
Boggs Anna E.,Schmitt Lauren M.,McLane Richard D.,Adayev Tatyana,LaFauci Giuseppe,Horn Paul S.,Dominick Kelli C.,Gross Christina,Erickson Craig A.
Abstract
AbstractFragile X Syndrome (FXS) is caused by a trinucleotide expansion leading to silencing of the FMR1 gene and lack of expression of Fragile X Protein (FXP, formerly known as Fragile X Mental Retardation Protein, FMRP). Phenotypic presentation of FXS is highly variable, and the lack of reproducible, sensitive assays to detect FXP makes evaluation of peripheral FXP as a source of clinical variability challenging. We optimized a Luminex-based assay to detect FXP in dried blot spots for increased reproducibility and sensitivity by improving reagent concentrations and buffer conditions. The optimized assay was used to quantify FXP in 187 individuals. We show that the optimized assay is highly reproducible and detects a wide range of FXP levels. Mosaic individuals had, on average, higher FXP levels than fully methylated individuals, and trace amounts of FXP were consistently detectable in a subset of individuals with full mutation FXS. IQ scores were positively correlated with FXP levels in males and females with full mutation FXS demonstrating the clinical utility of this method. Our data suggest trace amounts of FXP detectable in dried blood spots of individuals with FXS could be clinically relevant and may be used to stratify individuals with FXS for optimized treatment.
Funder
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Hagerman, R. J. Fragile X Syndrome: Molecular and clinical insights and treatment issues. West. J. Med. 166, 129–137 (1997).
2. Pieretti, M. et al. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66, 817–822 (1991).
3. Goldson, E. & Hagerman, R. J. The Fragile X Syndrome. Dev. Med. Child Neurol. 34, 826–832 (1992).
4. Darnell, J. C. & Klann, E. The translation of translational control by FMRP: Therapeutic targets for FXS. Nat. Neurosci. 16, 1530–1536. https://doi.org/10.1038/nn.3379 (2013).
5. Kaufmann, W. E., Abrams, M. T., Chen, W. & Reiss, A. L. Genotype, molecular phenotype, and cognitive phenotype: Correlations in fragile X syndrome. Am. J. Med. Genet. 83, 286–295 (1999).
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献